New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
A new imaging technology to grade tumour biopsies has been developed by a team of scientists led by the Department of Physics and the Department of Surgery and Cancer at Imperial College London.
Publishing their results today in the journal Convergent Science Physical Oncology, they describe how their new method promises to significantly reduce the subjectivity and variability in grading the severity of cancers.
[Digistain] is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis.Professor Chris Phillips
Nearly all cancers are still diagnosed by doctors taking a sample of the tumour, a so-called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years. They look at this ‘H+E stained’ sample under a microscope and then judge the severity of the disease by eye alone.
Life-changing treatment decisions have to be based on this ‘grading’ process, yet it is well known that different practitioners given the same slice will only agree on its grade about 70% of the time, resulting in an overtreatment problem.
The team’s new ‘Digistain’ technology addresses this problem by using invisible mid-infrared light to photograph the tissue slices in a way that maps out the chemical changes that signal the onset of cancer. In particular, they measure the ‘nuclear-to-cytoplasmic-ratio’ (NCR): a recognized biological marker for a wide range of cancers.
Lead author Professor Chris Phillips, from the Department of Physics at Imperial, said: “Our machine gives a quantitative ‘Digistain index’ (DI) score, corresponding to the NCR, and this study shows that it is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis. “
In the experiment reported today, the team carried out a double-blind clinical pilot trial using two adjacent slices taken from 75 breast cancer biopsies. The first slice was graded by clinicians as usual, using the standard H+E protocol. It was also used to identify the so-called ‘region of interest’ (RoI), i.e. the part of the slice containing the tumour.
The team then used the Digistain imager to get a DI value averaged over the corresponding RoI on the other, unstained slice, and ran a statistical analysis on the results.
Professor Phillips said: “Even with this modest number of samples, the correlation we saw between the DI score and the H+E grade would only happen by chance 1 time in 1400 trials. The strength of this correlation makes us extremely optimistic that Digistain will be able to eliminate subjectivity and variability in biopsy grading.”
Proving its worth
The NCR factor that Digistain measures is known to be common to a wide range of cancers, as it occurs when the reproductive cell cycle gets disrupted in the tumour and cell nuclei get distorted with rogue DNA. It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.
At a practical level, the researchers say that the Digistain imaging technology can easily and cheaply be incorporated into existing hospital labs, and be used by their staff. Professor Philips added: “It’s easy to prove its worth by checking it with the thousands of existing biopsy specimens that are already held in hospital archives. Together these facts will smooth the path into the clinic, and it could be saving lives in only a couple of years.”
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
- Amarillo health experts fear cervical cancer could be on the rise, due to COIVD-19 impacton January 21, 2021 at 7:44 pm
Amarillo healthcare workers are already seeing diagnosis delays in some cancer cases because of COVID-19. Doctors say cervical caner is treatable and no woman has to die from it. With women putting ...
- Dustin Diamond undergoing chemotherapy treatments for canceron January 21, 2021 at 5:13 pm
Original “Saved by the Bell” star Dustin Diamond has begun undergoing chemotherapy treatments after being diagnosed with cancer, according to his representative ...
- Dustin Diamond Begins Chemotherapy for Stage 4 Lung Canceron January 21, 2021 at 3:13 pm
Dustin Diamond, who portrayed Screech on Saved by the Bell, has completed his first round of chemotherapy after being diagnosed with stage 4 lung cancer.
- Saved by the Bell's Dustin Diamond's Cancer Diagnosed as Stage IV Small-Cell Carcinomaon January 21, 2021 at 2:03 pm
Saved by the Bell alum Dustin Diamond confirmed his cancer diagnosis after being admitted to the hospital. "At this time we can confirm that Dustin does have cancer. Dustin Will disclose more ...
- Dustin Diamond’s Cancer Diagnosed as Stage IV Small-Cell Carcinomaon January 21, 2021 at 12:25 pm
Dustin Diamond’s cancer battle was confirmed on January 14 after he was hospitalized in Florida with an undisclosed illness — details ...
- Amir Khan expresses his heartache after mum is diagnosed with canceron January 21, 2021 at 2:35 am
Boxing star Amir Khan has shared his heartache after his mother is diagnosed with stage 4 cancer. Read his statement ...
- New technique can rapidly diagnose prostate cancer from urineon January 20, 2021 at 11:25 pm
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on PSA, a cancer factor in blood.
- Cancer can be precisely diagnosed using a urine test with artificial intelligenceon January 20, 2021 at 9:03 pm
The Korea Institute of Science and Technology(KIST) announced that the collaborative research team led by Dr. Kwan Hyi Lee from the Biomaterials Research Center and Professor In Gab Jeong from Asan ...
- How John Kruk overcame the mental hurdle of his cancer diagnosison January 20, 2021 at 9:18 am
John Kruk recently recalled those first few moments after his 1994 cancer diagnosis in an interview for NBC Sports’ HeadStrong initiative.
via Bing News